Neuropeptide Y: Potential role in recurrent developmental seizures

Peptides

Volumn 28, Issue 2, 2007, Pages 441-446

  Dubé, Celine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epilepsy; Febrile seizures; Hippocampus; Hyperthermia; Neuropeptide Y (NPY); Rat

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

BRAIN DEVELOPMENT; FEBRILE CONVULSION; GENE EXPRESSION; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SEIZURE; SEIZURE THRESHOLD; SYSTEMATIC REVIEW; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEUROPEPTIDE Y; RATS; RECURRENCE; SEIZURES, FEBRILE;

RATTUS;

EID: 33846687372     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.08.034     Document Type: Review

References (81)

1. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., and Siggins G.R. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221 (1983) 875-877
2. Practice Parameter: Long-term Treatment of the Child With Simple Febrile Seizures. Committee on Quality Improvement, Subcommittee on Febrile Seizures. Pediatrics 1999;103:1307-1309.
3. Annegers J.F., Hauser W.A., Shirts S.B., and Kurland L.T. Factors prognostic of unprovoked seizures after febrile convulsions. New Eng J Med 316 (1987) 493-498
4. Avishai-Eliner S., Brunson K.L., Sandman C.A., and Baram T.Z. Stressed-out, or in (utero)?. Trends Neurosci 25 (2002) 518-524
5. Bai F., Sozen M.A., Lukiw W.J., and Argyropoulos G. Expression of AgRP, NPY, POMC and CART in human fetal and adult hippocampus. Neuropeptides 39 (2005) 439-443
6. Baram T.Z. Mechanisms and outcome of febrile seizures: what have we learned from basic science approaches and what needs studying?. In: Baram T.Z., and Shinnar S. (Eds). Febrile seizures (2002), Academic, San Diego 325-328
7. Baram T.Z., and Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21 (1998) 471-476
8. Baram T.Z., Hirsch E., Snead III O.C., and Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 31 (1992) 488-494
9. Bellmann R., Widmann R., Olenik C., Meyer D.K., Maas D., Marksteiner J., et al. Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem 56 (1991) 525-530
10. Bender R.A., Dubé C., Gonzalez-Vega R., Mina E.W., and Baram T.Z. Mossy fiber plasticity and enhanced hippocampal excitability, without hippocampal cell loss or altered neurogenesis, in an animal model of prolonged febrile seizures. Hippocampus 13 (2003) 399-412
11. Bender R.A., Dubé C., and Baram T.Z. Febrile seizures and mechanisms of epileptogenesis: insights from an animal model. Adv Exp Med Biol 548 (2004) 213-225
12. Bender R.A., Soleymani S.V., Brewster A.L., Nguyen S.T., Beck H., Mathern G.W., et al. Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J Neurosci 23 (2003) 6826-6836
13. Bendotti C., Vezzani A., Serafini R., Servadio A., Rivolta R., and Samanin R. Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: comparison with the expression of preprosomatostatin mRNA. Neurosci Lett 132 (1991) 175-178
14. Berg A.T., Shinnar S., Hauser W.A., Alemany M., Shapiro E.D., Salomon M.E., et al. A prospective study of recurrent febrile seizures. N Engl J Med 327 (1992) 1122-1127
15. Berg A.T., and Shinnar S. Complex febrile seizures. Epilepsia 37 (1996) 126-133
16. Berg A.T., Shinnar S., Darefsky A.S., Holford T.R., Shapiro E.D., Salomon M.E., et al. Predictors of recurrent febrile seizures. A prospective cohort study. Arch Pediatr Adolesc Med 151 (1997) 371-378
17. Bregola G., Dumont Y., Fournier A., Zucchini S., Quirion R., and Simonato M. Decreased levels of neuropeptide Y(5) receptor binding sites in two experimental models of epilepsy. Neuroscience 98 (2000) 697-703
18. Brewster A., Bender R.A., Chen Y., Dubé C., Eghbal-Ahmadi, and Baram T.Z. Developmental febrile seizures modulate hippocampal gene expression of hyperpolarization-activated channels in an isoform- and cell-specific manner. J Neurosci 22 (2002) 4591-4599
19. Brewster A.L., Bernard J.A., Gall C.M., and Baram T.Z. Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures. Neurobiol Dis 19 (2005) 200-207
20. Brunson K.L., Eghbal-Ahmadi M., Bender R., Chen Y., and Baram T.Z. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci USA 98 (2001) 8856-8861
21. Cendes F., Andermann F., Dubeau F., Gloor P., Evans A., Jones-Gotman M., et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 43 (1993) 1083-1087
22. Cendes F., and Andermann F. Do febrile seizures promote temporal lobe epilepsy? Retrospective studies. In: Baram T.Z., and Shinnar S. (Eds). Febrile seizures (2002), Academic, San Diego 77-86
23. Chen K., Aradi I., Thon N., Eghbal-Ahmadi M., Baram T.Z., and Soltesz I. Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7 (2001) 331-337
24. Chen K., Baram T.Z., and Soltesz I. Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 5 (1999) 888-894
25. Chen Y., Bender R., Frotscher M., and Baram T.Z. Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci 21 (2001) 7171-7181
26. Colmers W.F., and Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17 (1994) 373-379
27. Colmers W.F., Lukowiak K., and Pittman Q.J. Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci 8 (1988) 3827-3837
28. Commission on Classification and Terminology of the International League Against Epilepsy: proposal for revised clinical and eletroencephalographic classification of epileptic seizures. Epilepsia 33 (1981) 661-666
29. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., and Esser F. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 384 (1999) R3-R5
30. Dubé C.M., and Baram T.Z. Complex febrile seizures-an experimental model in immature rodent. In: Pitkanen A., Schwartzkroin P.A., and Moshe S.L. (Eds). Models of seizures and epilepsy (2005), Elsevier, San Diego 333-340
31. Dubé C., Brunson K.L., Eghbal-Ahmadi M., Gonzalez-Vega R., and Baram T.Z. Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold. J Mol Neurosci 25 (2005) 275-284
32. Dubé C., Chen K., Eghbal-Ahmadi M., Brunson K., Soltesz I., and Baram T.Z. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long-term. Ann Neurol 47 (2000) 336-344
33. Dubé C., Richichi C., Bender R.A., Chung G., Litt B., and Baram T.Z. Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 129 (2006) 911-922
34. Dubé C., Vezzani A., Behrens M., Bartfai T., and Baram T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57 (2005) 152-155
35. Dubé C., Yu H., Nalcioglu O., and Baram T.Z. Serial MRI after prolonged experimental febrile seizures: altered T2 signal does not signify neuronal death. Ann Neurol 56 (2004) 709-714
36. Dumont Y., Cadieux A., Doods H., Pheng L.H., Abounader R., Hamel E., et al. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol 129 (2000) 1075-1088
37. El Bahh B., Cao J.Q., Beck-Sickinger A.G., and Colmers W.F. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. Br J Pharmacol 136 (2002) 502-509
38. French J.A., Williamson P.D., Thadani V.M., Darcey T.M., Mattson R.H., Spencer S.S., et al. Characteristics of medial temporal lobe epilepsy. I. Results of history and physical examination. Ann Neurol 34 (1993) 774-780
39. Freund T.F., and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6 (1996) 347-470
40. Furtinger S., Pirker S., Czech T., Baumgartner C., Ransmayr G., and Sperk G. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci 21 (2001) 5804-5812
41. Gatti S., Vezzani A., and Bartfai T. Mechanisms of fever and febrile seizures: putative role of interleukin-1 system. In: Baram T.Z., and Shinnar S. (Eds). Febrile seizures (2002), Academic, San Diego 169-188
42. Greber S., Schwarzer C., and Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113 (1994) 737-740
43. Gruber B., Greber S., Rupp E., and Sperk G. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4 (1994) 474-482
44. Hamati-Haddad A., and Abou-Khalil B. Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions. Neurology 50 (1998) 917-922
45. Hatalski C.G., Brunson K.L., Tantayanubutr B., Chen Y., and Baram T.Z. Neuronal activity and stress differentially regulate hippocampal and hypothalamic corticotropin-releasing hormone expression in the immature rat. Neuroscience 101 (2000) 571-580
46. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia 35 (1994) S1-S6
47. Hokfelt T. Neuropeptides in perspective: the last ten years. Neuron 7 (1991) 867-879
48. Hokfelt T., Broberger C., Xu Z.Q., Sergeyev V., Ubink R., and Diez M. Neuropeptides-an overview. Neuropharmacology 39 (2000) 1337-1356
49. Hollrigel G.S., Chen K., Baram T.Z., and Soltesz I. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 84 (1998) 71-79
50. Klapstein G.J., and Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3 (1993) 103-111
51. Klapstein G.J., and Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78 (1997) 1651-1661
52. Lewis D.V. Febrile convulsions and mesial temporal sclerosis. Curr Opin Neurol 12 (1999) 197-201
53. Lotstra F., Schiffmann S.N., and Vanderhaeghen J.J. Neuropeptide Y-containing neurons in the human infant hippocampus. Brain Res 478 (1989) 211-226
54. Mathern G.W., Babb T.L., Pretorius J.K., and Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 15 (1995) 3990-4004
55. Nelson K.B., and Ellenberg J.H. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med 295 (1976) 1029-1033
56. Nelson K.B., and Ellenberg J.H. Prognosis in children with febrile seizures. Pediatrics 61 (1978) 720-727
57. Nelson K.B., and Ellenberg J.H. Febrile seizures (1981), Raven Press, New York
58. Patrylo P.R., van den Pol A.N., Spencer D.D., and Williamson A. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 82 (1999) 478-483
59. 2+ entry. J Neurosci 17 (1997) 8169-8177
60. Redrobe J.P., Dumont Y., St-Pierre J.A., and Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res 848 (1999) 153-166
61. Rizzi M., Monno A., Samanin R., Sperk G., and Vezzani A. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur J Neurosci 5 (1993) 1534-1538
62. Roder C., Schwarzer C., Vezzani A., Gobbi M., Mennini T., and Sperk G. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience 70 (1996) 47-55
63. Rothwell N.J., and Luheshi G.N. Pharmacology of interleukin-1 actions in the brain. Adv Pharmacol 25 (1994) 1-20
64. Rothwell N.J., and Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23 (2000) 618-625
65. Sadamatsu M., Kanai H., Masui A., Serikawa T., Yamada J., Sasa M., et al. Altered brain contents of neuropeptides in spontaneously epileptic rats (SER) and tremor rats with absence seizures. Life Sci 57 (1995) 523-531
66. Santoro B., and Baram T.Z. The multiple personalities of h-channels. Trends Neurosci 26 (2003) 550-554
67. Schwarzer C., Kofler N., and Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53 (1998) 6-13
68. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., and Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 69 (1995) 831-845
69. Shinnar S. Do febrile seizures lead to temporal lobe epilepsy? Prospective and epidemiological studies. In: Baram T.Z., and Shinnar S. (Eds). Febrile seizures (2002), Academic, San Diego 87-101
70. Silva A.P., Carvalho A.P., Carvalho C.M., and Malva J.O. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44 (2003) 282-292
71. Stafstrom C.E. The incidence and prevalence of febrile seizures. In: Baram T.Z., and Shinnar S. (Eds). Febrile seizures (2002), Academic, San Diego 1-25
72. Theodore W.H., Bhatia S., Hatta J., Fazilat S., DeCarli C., Bookheimer S.Y., et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology 52 (1999) 132-136
73. Toth Z., Yan X.X., Haftoglou S., Ribak C.E., and Baram T.Z. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 18 (1998) 4285-4294
74. Tu B., Timofeeva O., Jiao Y., and Nadler J.V. Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 25 (2005) 1718-1729
75. Vezzani A., Civenni G., Rizzi M., Monno A., Messali S., and Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res 660 (1994) 138-143
76. Vezzani A., Monhemius R., Tutka P., Milani R., and Samanin R. Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats. Neuroscience 75 (1996) 551-557
77. Vezzani A., Schwarzer C., Lothman E.W., Williamson J., and Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res 26 (1996) 267-279
78. Vezzani A., Sperk G., and Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22 (1999) 25-30
79. Woldbye D.P. Antiepileptic effects of NPY on pentylenetetrazole seizures. Regul Pept 75-76 (1998) 279-282
80. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., and Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med 3 (1997) 761-764
81. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., and Bolwig T.G. Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res 737 (1996) 162-168